nodes	percent_of_prediction	percent_of_DWPC	metapath
Levobupivacaine—CYP1A2—Citalopram—alcohol dependence	0.221	0.443	CbGbCtD
Levobupivacaine—CYP3A4—Disulfiram—alcohol dependence	0.162	0.325	CbGbCtD
Levobupivacaine—CYP3A4—Citalopram—alcohol dependence	0.116	0.232	CbGbCtD
Levobupivacaine—CYP3A4—Felbamate Metabolism—CYP2E1—alcohol dependence	0.00522	0.0613	CbGpPWpGaD
Levobupivacaine—CYP1A2—Fatty Acid Omega Oxidation—ADH6—alcohol dependence	0.00433	0.0509	CbGpPWpGaD
Levobupivacaine—SCN10A—nerve—alcohol dependence	0.00367	0.221	CbGeAlD
Levobupivacaine—CYP1A2—Fatty Acid Omega Oxidation—ADH1A—alcohol dependence	0.00359	0.0421	CbGpPWpGaD
Levobupivacaine—CYP3A4—Fatty Acid Omega Oxidation—ADH6—alcohol dependence	0.00334	0.0392	CbGpPWpGaD
Levobupivacaine—CYP1A2—Fatty Acid Omega Oxidation—ADH4—alcohol dependence	0.00305	0.0358	CbGpPWpGaD
Levobupivacaine—CYP3A4—Fatty Acid Omega Oxidation—ADH1A—alcohol dependence	0.00277	0.0325	CbGpPWpGaD
Levobupivacaine—Urinary incontinence—Acamprosate—alcohol dependence	0.00275	0.0069	CcSEcCtD
Levobupivacaine—Muscle twitching—Naltrexone—alcohol dependence	0.00275	0.00688	CcSEcCtD
Levobupivacaine—Blood pressure increased—Naltrexone—alcohol dependence	0.0027	0.00676	CcSEcCtD
Levobupivacaine—Electrocardiogram abnormal—Citalopram—alcohol dependence	0.00261	0.00653	CcSEcCtD
Levobupivacaine—CYP1A2—Fatty Acid Omega Oxidation—ADH7—alcohol dependence	0.00259	0.0305	CbGpPWpGaD
Levobupivacaine—Hypokinesia—Citalopram—alcohol dependence	0.00253	0.00634	CcSEcCtD
Levobupivacaine—Paralysis—Citalopram—alcohol dependence	0.00246	0.00616	CcSEcCtD
Levobupivacaine—CYP3A4—Fatty Acid Omega Oxidation—ADH4—alcohol dependence	0.00235	0.0276	CbGpPWpGaD
Levobupivacaine—Euphoric mood—Naltrexone—alcohol dependence	0.00232	0.00581	CcSEcCtD
Levobupivacaine—Ventricular arrhythmia—Citalopram—alcohol dependence	0.00231	0.00578	CcSEcCtD
Levobupivacaine—CYP1A2—Tryptophan metabolism—ALDH3A2—alcohol dependence	0.00228	0.0268	CbGpPWpGaD
Levobupivacaine—CYP1A2—Fatty Acid Omega Oxidation—ADH1B—alcohol dependence	0.00227	0.0267	CbGpPWpGaD
Levobupivacaine—Injury—Acamprosate—alcohol dependence	0.00225	0.00564	CcSEcCtD
Levobupivacaine—Fungal infection—Citalopram—alcohol dependence	0.00221	0.00554	CcSEcCtD
Levobupivacaine—Feeling hot—Citalopram—alcohol dependence	0.00218	0.00545	CcSEcCtD
Levobupivacaine—CYP1A2—Aflatoxin activation and detoxification—GGT2—alcohol dependence	0.00217	0.0255	CbGpPWpGaD
Levobupivacaine—Rigors—Citalopram—alcohol dependence	0.00209	0.00524	CcSEcCtD
Levobupivacaine—Diplopia—Acamprosate—alcohol dependence	0.00207	0.00518	CcSEcCtD
Levobupivacaine—Pallor—Citalopram—alcohol dependence	0.00206	0.00516	CcSEcCtD
Levobupivacaine—Purpura—Naltrexone—alcohol dependence	0.00203	0.00509	CcSEcCtD
Levobupivacaine—Extrasystoles—Citalopram—alcohol dependence	0.00203	0.00509	CcSEcCtD
Levobupivacaine—CYP3A4—Fatty Acid Omega Oxidation—ADH7—alcohol dependence	0.002	0.0235	CbGpPWpGaD
Levobupivacaine—Lethargy—Naltrexone—alcohol dependence	0.002	0.00501	CcSEcCtD
Levobupivacaine—Breast pain—Citalopram—alcohol dependence	0.00196	0.00491	CcSEcCtD
Levobupivacaine—Cardiovascular disorder—Citalopram—alcohol dependence	0.00195	0.00487	CcSEcCtD
Levobupivacaine—Blood creatinine increased—Acamprosate—alcohol dependence	0.00194	0.00486	CcSEcCtD
Levobupivacaine—Musculoskeletal stiffness—Citalopram—alcohol dependence	0.00191	0.00477	CcSEcCtD
Levobupivacaine—Skin discolouration—Citalopram—alcohol dependence	0.00189	0.00474	CcSEcCtD
Levobupivacaine—Bone disorder—Citalopram—alcohol dependence	0.00189	0.00474	CcSEcCtD
Levobupivacaine—Orthostatic hypotension—Acamprosate—alcohol dependence	0.00189	0.00473	CcSEcCtD
Levobupivacaine—Hypocalcaemia—Citalopram—alcohol dependence	0.00187	0.00468	CcSEcCtD
Levobupivacaine—Aspartate aminotransferase increased—Acamprosate—alcohol dependence	0.00186	0.00467	CcSEcCtD
Levobupivacaine—Paraesthesia—Disulfiram—alcohol dependence	0.00185	0.00464	CcSEcCtD
Levobupivacaine—Somnolence—Disulfiram—alcohol dependence	0.00184	0.0046	CcSEcCtD
Levobupivacaine—Alanine aminotransferase increased—Acamprosate—alcohol dependence	0.00183	0.00457	CcSEcCtD
Levobupivacaine—Leukocytosis—Citalopram—alcohol dependence	0.00182	0.00456	CcSEcCtD
Levobupivacaine—Dysarthria—Citalopram—alcohol dependence	0.00181	0.00453	CcSEcCtD
Levobupivacaine—Blood bilirubin increased—Citalopram—alcohol dependence	0.00181	0.00453	CcSEcCtD
Levobupivacaine—Abdominal distension—Acamprosate—alcohol dependence	0.0018	0.00451	CcSEcCtD
Levobupivacaine—Dysphagia—Acamprosate—alcohol dependence	0.00179	0.00448	CcSEcCtD
Levobupivacaine—Pain—Disulfiram—alcohol dependence	0.00177	0.00442	CcSEcCtD
Levobupivacaine—Aspartate aminotransferase increased—Naltrexone—alcohol dependence	0.00176	0.00442	CcSEcCtD
Levobupivacaine—CYP3A4—Tryptophan metabolism—ALDH3A2—alcohol dependence	0.00176	0.0207	CbGpPWpGaD
Levobupivacaine—CYP3A4—Fatty Acid Omega Oxidation—ADH1B—alcohol dependence	0.00175	0.0206	CbGpPWpGaD
Levobupivacaine—Muscle twitching—Citalopram—alcohol dependence	0.00174	0.00436	CcSEcCtD
Levobupivacaine—Neck pain—Citalopram—alcohol dependence	0.00173	0.00433	CcSEcCtD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—ALDH3A1—alcohol dependence	0.00173	0.0203	CbGpPWpGaD
Levobupivacaine—Alanine aminotransferase increased—Naltrexone—alcohol dependence	0.00173	0.00433	CcSEcCtD
Levobupivacaine—Blood pressure increased—Citalopram—alcohol dependence	0.00171	0.00428	CcSEcCtD
Levobupivacaine—Ventricular tachycardia—Citalopram—alcohol dependence	0.00171	0.00428	CcSEcCtD
Levobupivacaine—CYP3A4—Aflatoxin activation and detoxification—GGT2—alcohol dependence	0.00167	0.0196	CbGpPWpGaD
Levobupivacaine—Urinary incontinence—Citalopram—alcohol dependence	0.00165	0.00413	CcSEcCtD
Levobupivacaine—Depressed level of consciousness—Citalopram—alcohol dependence	0.00165	0.00413	CcSEcCtD
Levobupivacaine—Sweating increased—Naltrexone—alcohol dependence	0.00165	0.00413	CcSEcCtD
Levobupivacaine—Neuropathy—Citalopram—alcohol dependence	0.0016	0.00402	CcSEcCtD
Levobupivacaine—CYP1A2—Fatty Acid Omega Oxidation—ALDH2—alcohol dependence	0.0016	0.0188	CbGpPWpGaD
Levobupivacaine—Urinary tract infection—Acamprosate—alcohol dependence	0.00155	0.00388	CcSEcCtD
Levobupivacaine—Lightheadedness—Citalopram—alcohol dependence	0.00153	0.00383	CcSEcCtD
Levobupivacaine—Sweating—Acamprosate—alcohol dependence	0.00153	0.00383	CcSEcCtD
Levobupivacaine—SCN10A—forebrain—alcohol dependence	0.00152	0.0914	CbGeAlD
Levobupivacaine—Haematuria—Acamprosate—alcohol dependence	0.00152	0.00381	CcSEcCtD
Levobupivacaine—Infestation NOS—Naltrexone—alcohol dependence	0.00151	0.00378	CcSEcCtD
Levobupivacaine—Infestation—Naltrexone—alcohol dependence	0.00151	0.00378	CcSEcCtD
Levobupivacaine—Asthenia—Disulfiram—alcohol dependence	0.00148	0.00371	CcSEcCtD
Levobupivacaine—Euphoric mood—Citalopram—alcohol dependence	0.00147	0.00368	CcSEcCtD
Levobupivacaine—Urinary tract infection—Naltrexone—alcohol dependence	0.00147	0.00367	CcSEcCtD
Levobupivacaine—Hypoaesthesia—Acamprosate—alcohol dependence	0.00142	0.00357	CcSEcCtD
Levobupivacaine—Oedema peripheral—Acamprosate—alcohol dependence	0.00141	0.00353	CcSEcCtD
Levobupivacaine—Vascular purpura—Citalopram—alcohol dependence	0.00139	0.00347	CcSEcCtD
Levobupivacaine—Dizziness—Disulfiram—alcohol dependence	0.00137	0.00342	CcSEcCtD
Levobupivacaine—Injury—Citalopram—alcohol dependence	0.00135	0.00338	CcSEcCtD
Levobupivacaine—Tinnitus—Acamprosate—alcohol dependence	0.00134	0.00334	CcSEcCtD
Levobupivacaine—Headache—Disulfiram—alcohol dependence	0.00129	0.00324	CcSEcCtD
Levobupivacaine—Purpura—Citalopram—alcohol dependence	0.00129	0.00322	CcSEcCtD
Levobupivacaine—Chills—Acamprosate—alcohol dependence	0.00128	0.00322	CcSEcCtD
Levobupivacaine—CYP1A2—Fatty Acid Omega Oxidation—CYP2E1—alcohol dependence	0.00128	0.015	CbGpPWpGaD
Levobupivacaine—Lethargy—Citalopram—alcohol dependence	0.00127	0.00317	CcSEcCtD
Levobupivacaine—Tinnitus—Naltrexone—alcohol dependence	0.00126	0.00316	CcSEcCtD
Levobupivacaine—Cardiac disorder—Naltrexone—alcohol dependence	0.00126	0.00315	CcSEcCtD
Levobupivacaine—Mental disorder—Acamprosate—alcohol dependence	0.00125	0.00314	CcSEcCtD
Levobupivacaine—Malnutrition—Acamprosate—alcohol dependence	0.00125	0.00312	CcSEcCtD
Levobupivacaine—Osteoarthritis—Citalopram—alcohol dependence	0.00124	0.00311	CcSEcCtD
Levobupivacaine—Diplopia—Citalopram—alcohol dependence	0.00124	0.00311	CcSEcCtD
Levobupivacaine—CYP3A4—Fatty Acid Omega Oxidation—ALDH2—alcohol dependence	0.00124	0.0145	CbGpPWpGaD
Levobupivacaine—Flatulence—Acamprosate—alcohol dependence	0.00123	0.00308	CcSEcCtD
Levobupivacaine—Tension—Acamprosate—alcohol dependence	0.00122	0.00306	CcSEcCtD
Levobupivacaine—CYP1A2—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.00122	0.0143	CbGpPWpGaD
Levobupivacaine—Chills—Naltrexone—alcohol dependence	0.00122	0.00304	CcSEcCtD
Levobupivacaine—Nervousness—Acamprosate—alcohol dependence	0.00121	0.00303	CcSEcCtD
Levobupivacaine—Back pain—Acamprosate—alcohol dependence	0.00121	0.00302	CcSEcCtD
Levobupivacaine—Muscle spasms—Acamprosate—alcohol dependence	0.0012	0.003	CcSEcCtD
Levobupivacaine—Mental disorder—Naltrexone—alcohol dependence	0.00119	0.00297	CcSEcCtD
Levobupivacaine—Urinary retention—Citalopram—alcohol dependence	0.00118	0.00296	CcSEcCtD
Levobupivacaine—Cardiac arrest—Citalopram—alcohol dependence	0.00118	0.00296	CcSEcCtD
Levobupivacaine—Malnutrition—Naltrexone—alcohol dependence	0.00118	0.00295	CcSEcCtD
Levobupivacaine—Tremor—Acamprosate—alcohol dependence	0.00117	0.00293	CcSEcCtD
Levobupivacaine—Flatulence—Naltrexone—alcohol dependence	0.00116	0.00291	CcSEcCtD
Levobupivacaine—Tension—Naltrexone—alcohol dependence	0.00116	0.0029	CcSEcCtD
Levobupivacaine—Anaemia—Acamprosate—alcohol dependence	0.00115	0.00289	CcSEcCtD
Levobupivacaine—Agitation—Acamprosate—alcohol dependence	0.00115	0.00287	CcSEcCtD
Levobupivacaine—Nervousness—Naltrexone—alcohol dependence	0.00115	0.00287	CcSEcCtD
Levobupivacaine—Back pain—Naltrexone—alcohol dependence	0.00114	0.00286	CcSEcCtD
Levobupivacaine—Angioedema—Acamprosate—alcohol dependence	0.00114	0.00285	CcSEcCtD
Levobupivacaine—Muscle spasms—Naltrexone—alcohol dependence	0.00113	0.00284	CcSEcCtD
Levobupivacaine—Orthostatic hypotension—Citalopram—alcohol dependence	0.00113	0.00284	CcSEcCtD
Levobupivacaine—Syncope—Acamprosate—alcohol dependence	0.00112	0.0028	CcSEcCtD
Levobupivacaine—Aspartate aminotransferase increased—Citalopram—alcohol dependence	0.00112	0.0028	CcSEcCtD
Levobupivacaine—Vision blurred—Naltrexone—alcohol dependence	0.00111	0.00278	CcSEcCtD
Levobupivacaine—Tremor—Naltrexone—alcohol dependence	0.0011	0.00277	CcSEcCtD
Levobupivacaine—Palpitations—Acamprosate—alcohol dependence	0.0011	0.00276	CcSEcCtD
Levobupivacaine—Loss of consciousness—Acamprosate—alcohol dependence	0.0011	0.00274	CcSEcCtD
Levobupivacaine—Alanine aminotransferase increased—Citalopram—alcohol dependence	0.00109	0.00274	CcSEcCtD
Levobupivacaine—Muscular weakness—Citalopram—alcohol dependence	0.00109	0.00274	CcSEcCtD
Levobupivacaine—Cough—Acamprosate—alcohol dependence	0.00109	0.00272	CcSEcCtD
Levobupivacaine—Agitation—Naltrexone—alcohol dependence	0.00108	0.00271	CcSEcCtD
Levobupivacaine—Convulsion—Acamprosate—alcohol dependence	0.00108	0.00271	CcSEcCtD
Levobupivacaine—Abdominal distension—Citalopram—alcohol dependence	0.00108	0.0027	CcSEcCtD
Levobupivacaine—Angioedema—Naltrexone—alcohol dependence	0.00108	0.0027	CcSEcCtD
Levobupivacaine—Hypertension—Acamprosate—alcohol dependence	0.00108	0.0027	CcSEcCtD
Levobupivacaine—Dysphagia—Citalopram—alcohol dependence	0.00107	0.00269	CcSEcCtD
Levobupivacaine—CYP1A2—Xenobiotics—CYP2E1—alcohol dependence	0.00107	0.0126	CbGpPWpGaD
Levobupivacaine—Arthralgia—Acamprosate—alcohol dependence	0.00106	0.00266	CcSEcCtD
Levobupivacaine—Syncope—Naltrexone—alcohol dependence	0.00106	0.00265	CcSEcCtD
Levobupivacaine—Anxiety—Acamprosate—alcohol dependence	0.00106	0.00265	CcSEcCtD
Levobupivacaine—Bronchospasm—Citalopram—alcohol dependence	0.00105	0.00264	CcSEcCtD
Levobupivacaine—Unspecified disorder of skin and subcutaneous tissue—Acamprosate—alcohol dependence	0.00105	0.00264	CcSEcCtD
Levobupivacaine—Sweating increased—Citalopram—alcohol dependence	0.00104	0.00262	CcSEcCtD
Levobupivacaine—Palpitations—Naltrexone—alcohol dependence	0.00104	0.00261	CcSEcCtD
Levobupivacaine—Loss of consciousness—Naltrexone—alcohol dependence	0.00104	0.0026	CcSEcCtD
Levobupivacaine—CYP1A2—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.00103	0.0121	CbGpPWpGaD
Levobupivacaine—Cough—Naltrexone—alcohol dependence	0.00103	0.00258	CcSEcCtD
Levobupivacaine—Confusional state—Acamprosate—alcohol dependence	0.00103	0.00257	CcSEcCtD
Levobupivacaine—CYP1A2—Aflatoxin activation and detoxification—GGT1—alcohol dependence	0.00102	0.012	CbGpPWpGaD
Levobupivacaine—Convulsion—Naltrexone—alcohol dependence	0.00102	0.00256	CcSEcCtD
Levobupivacaine—Hypertension—Naltrexone—alcohol dependence	0.00102	0.00255	CcSEcCtD
Levobupivacaine—SCN10A—blood—alcohol dependence	0.00102	0.0612	CbGeAlD
Levobupivacaine—Anaphylactic shock—Acamprosate—alcohol dependence	0.00102	0.00255	CcSEcCtD
Levobupivacaine—Infection—Acamprosate—alcohol dependence	0.00101	0.00253	CcSEcCtD
Levobupivacaine—CYP1A2—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.00101	0.0119	CbGpPWpGaD
Levobupivacaine—Arthralgia—Naltrexone—alcohol dependence	0.001	0.00251	CcSEcCtD
Levobupivacaine—Shock—Acamprosate—alcohol dependence	0.001	0.00251	CcSEcCtD
Levobupivacaine—Anxiety—Naltrexone—alcohol dependence	0.001	0.00251	CcSEcCtD
Levobupivacaine—Unspecified disorder of skin and subcutaneous tissue—Naltrexone—alcohol dependence	0.000997	0.0025	CcSEcCtD
Levobupivacaine—Tachycardia—Acamprosate—alcohol dependence	0.000993	0.00249	CcSEcCtD
Levobupivacaine—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—alcohol dependence	0.000988	0.0116	CbGpPWpGaD
Levobupivacaine—Skin disorder—Acamprosate—alcohol dependence	0.000988	0.00247	CcSEcCtD
Levobupivacaine—SCN4A—testis—alcohol dependence	0.000986	0.0593	CbGeAlD
Levobupivacaine—Hyperhidrosis—Acamprosate—alcohol dependence	0.000983	0.00246	CcSEcCtD
Levobupivacaine—Confusional state—Naltrexone—alcohol dependence	0.000971	0.00243	CcSEcCtD
Levobupivacaine—SCN4A—nervous system—alcohol dependence	0.000968	0.0582	CbGeAlD
Levobupivacaine—Oedema—Naltrexone—alcohol dependence	0.000963	0.00241	CcSEcCtD
Levobupivacaine—Anaphylactic shock—Naltrexone—alcohol dependence	0.000963	0.00241	CcSEcCtD
Levobupivacaine—Infection—Naltrexone—alcohol dependence	0.000956	0.0024	CcSEcCtD
Levobupivacaine—Infestation NOS—Citalopram—alcohol dependence	0.000956	0.0024	CcSEcCtD
Levobupivacaine—Infestation—Citalopram—alcohol dependence	0.000956	0.0024	CcSEcCtD
Levobupivacaine—Hypotension—Acamprosate—alcohol dependence	0.000951	0.00238	CcSEcCtD
Levobupivacaine—Shock—Naltrexone—alcohol dependence	0.000947	0.00237	CcSEcCtD
Levobupivacaine—Nervous system disorder—Naltrexone—alcohol dependence	0.000944	0.00236	CcSEcCtD
Levobupivacaine—CYP3A4—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.000941	0.0111	CbGpPWpGaD
Levobupivacaine—Tachycardia—Naltrexone—alcohol dependence	0.000939	0.00235	CcSEcCtD
Levobupivacaine—Neuropathy peripheral—Citalopram—alcohol dependence	0.000937	0.00235	CcSEcCtD
Levobupivacaine—Skin disorder—Naltrexone—alcohol dependence	0.000935	0.00234	CcSEcCtD
Levobupivacaine—SCN4A—central nervous system—alcohol dependence	0.000932	0.056	CbGeAlD
Levobupivacaine—Hyperhidrosis—Naltrexone—alcohol dependence	0.00093	0.00233	CcSEcCtD
Levobupivacaine—Urinary tract infection—Citalopram—alcohol dependence	0.000929	0.00233	CcSEcCtD
Levobupivacaine—Musculoskeletal discomfort—Acamprosate—alcohol dependence	0.000927	0.00232	CcSEcCtD
Levobupivacaine—Insomnia—Acamprosate—alcohol dependence	0.00092	0.0023	CcSEcCtD
Levobupivacaine—Sweating—Citalopram—alcohol dependence	0.000917	0.0023	CcSEcCtD
Levobupivacaine—Paraesthesia—Acamprosate—alcohol dependence	0.000913	0.00229	CcSEcCtD
Levobupivacaine—Haematuria—Citalopram—alcohol dependence	0.000912	0.00228	CcSEcCtD
Levobupivacaine—Dyspnoea—Acamprosate—alcohol dependence	0.000907	0.00227	CcSEcCtD
Levobupivacaine—Somnolence—Acamprosate—alcohol dependence	0.000904	0.00227	CcSEcCtD
Levobupivacaine—Dyspepsia—Acamprosate—alcohol dependence	0.000895	0.00224	CcSEcCtD
Levobupivacaine—Decreased appetite—Acamprosate—alcohol dependence	0.000884	0.00222	CcSEcCtD
Levobupivacaine—SCN10A—endocrine gland—alcohol dependence	0.000883	0.053	CbGeAlD
Levobupivacaine—Gastrointestinal disorder—Acamprosate—alcohol dependence	0.000878	0.0022	CcSEcCtD
Levobupivacaine—Musculoskeletal discomfort—Naltrexone—alcohol dependence	0.000877	0.0022	CcSEcCtD
Levobupivacaine—Bradycardia—Citalopram—alcohol dependence	0.000874	0.00219	CcSEcCtD
Levobupivacaine—Insomnia—Naltrexone—alcohol dependence	0.000871	0.00218	CcSEcCtD
Levobupivacaine—Pain—Acamprosate—alcohol dependence	0.00087	0.00218	CcSEcCtD
Levobupivacaine—Constipation—Acamprosate—alcohol dependence	0.00087	0.00218	CcSEcCtD
Levobupivacaine—Paraesthesia—Naltrexone—alcohol dependence	0.000864	0.00216	CcSEcCtD
Levobupivacaine—CYP1A2—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.000859	0.0101	CbGpPWpGaD
Levobupivacaine—Dyspnoea—Naltrexone—alcohol dependence	0.000858	0.00215	CcSEcCtD
Levobupivacaine—Somnolence—Naltrexone—alcohol dependence	0.000856	0.00214	CcSEcCtD
Levobupivacaine—Hypoaesthesia—Citalopram—alcohol dependence	0.000854	0.00214	CcSEcCtD
Levobupivacaine—Oedema peripheral—Citalopram—alcohol dependence	0.000846	0.00212	CcSEcCtD
Levobupivacaine—Feeling abnormal—Acamprosate—alcohol dependence	0.000838	0.0021	CcSEcCtD
Levobupivacaine—Decreased appetite—Naltrexone—alcohol dependence	0.000837	0.0021	CcSEcCtD
Levobupivacaine—Gastrointestinal pain—Acamprosate—alcohol dependence	0.000832	0.00208	CcSEcCtD
Levobupivacaine—Gastrointestinal disorder—Naltrexone—alcohol dependence	0.000831	0.00208	CcSEcCtD
Levobupivacaine—CYP3A4—Xenobiotics—CYP2E1—alcohol dependence	0.000827	0.00971	CbGpPWpGaD
Levobupivacaine—SCN10A—nervous system—alcohol dependence	0.000826	0.0496	CbGeAlD
Levobupivacaine—Pain—Naltrexone—alcohol dependence	0.000823	0.00206	CcSEcCtD
Levobupivacaine—Constipation—Naltrexone—alcohol dependence	0.000823	0.00206	CcSEcCtD
Levobupivacaine—CYP1A2—Tryptophan metabolism—MAOB—alcohol dependence	0.000809	0.00951	CbGpPWpGaD
Levobupivacaine—Urticaria—Acamprosate—alcohol dependence	0.000808	0.00202	CcSEcCtD
Levobupivacaine—Abdominal pain—Acamprosate—alcohol dependence	0.000804	0.00201	CcSEcCtD
Levobupivacaine—Body temperature increased—Acamprosate—alcohol dependence	0.000804	0.00201	CcSEcCtD
Levobupivacaine—Tinnitus—Citalopram—alcohol dependence	0.0008	0.002	CcSEcCtD
Levobupivacaine—Cardiac disorder—Citalopram—alcohol dependence	0.000797	0.002	CcSEcCtD
Levobupivacaine—Flushing—Citalopram—alcohol dependence	0.000797	0.002	CcSEcCtD
Levobupivacaine—SCN10A—central nervous system—alcohol dependence	0.000795	0.0478	CbGeAlD
Levobupivacaine—CYP3A4—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.000795	0.00934	CbGpPWpGaD
Levobupivacaine—Feeling abnormal—Naltrexone—alcohol dependence	0.000793	0.00199	CcSEcCtD
Levobupivacaine—CYP3A4—Aflatoxin activation and detoxification—GGT1—alcohol dependence	0.000791	0.00929	CbGpPWpGaD
Levobupivacaine—Gastrointestinal pain—Naltrexone—alcohol dependence	0.000787	0.00197	CcSEcCtD
Levobupivacaine—CYP3A4—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.000779	0.00916	CbGpPWpGaD
Levobupivacaine—Chills—Citalopram—alcohol dependence	0.00077	0.00193	CcSEcCtD
Levobupivacaine—Arrhythmia—Citalopram—alcohol dependence	0.000767	0.00192	CcSEcCtD
Levobupivacaine—Urticaria—Naltrexone—alcohol dependence	0.000765	0.00192	CcSEcCtD
Levobupivacaine—Abdominal pain—Naltrexone—alcohol dependence	0.000761	0.00191	CcSEcCtD
Levobupivacaine—Body temperature increased—Naltrexone—alcohol dependence	0.000761	0.00191	CcSEcCtD
Levobupivacaine—Mental disorder—Citalopram—alcohol dependence	0.000752	0.00188	CcSEcCtD
Levobupivacaine—Hypersensitivity—Acamprosate—alcohol dependence	0.00075	0.00188	CcSEcCtD
Levobupivacaine—Malnutrition—Citalopram—alcohol dependence	0.000747	0.00187	CcSEcCtD
Levobupivacaine—Erythema—Citalopram—alcohol dependence	0.000747	0.00187	CcSEcCtD
Levobupivacaine—SCN4A—brain—alcohol dependence	0.00074	0.0445	CbGeAlD
Levobupivacaine—Flatulence—Citalopram—alcohol dependence	0.000736	0.00184	CcSEcCtD
Levobupivacaine—Tension—Citalopram—alcohol dependence	0.000733	0.00184	CcSEcCtD
Levobupivacaine—CYP1A2—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.00073	0.00858	CbGpPWpGaD
Levobupivacaine—Asthenia—Acamprosate—alcohol dependence	0.00073	0.00183	CcSEcCtD
Levobupivacaine—Nervousness—Citalopram—alcohol dependence	0.000726	0.00182	CcSEcCtD
Levobupivacaine—Back pain—Citalopram—alcohol dependence	0.000723	0.00181	CcSEcCtD
Levobupivacaine—Pruritus—Acamprosate—alcohol dependence	0.00072	0.0018	CcSEcCtD
Levobupivacaine—Muscle spasms—Citalopram—alcohol dependence	0.000718	0.0018	CcSEcCtD
Levobupivacaine—Hypersensitivity—Naltrexone—alcohol dependence	0.000709	0.00178	CcSEcCtD
Levobupivacaine—Vision blurred—Citalopram—alcohol dependence	0.000704	0.00176	CcSEcCtD
Levobupivacaine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—alcohol dependence	0.000701	0.00823	CbGpPWpGaD
Levobupivacaine—Tremor—Citalopram—alcohol dependence	0.0007	0.00175	CcSEcCtD
Levobupivacaine—Diarrhoea—Acamprosate—alcohol dependence	0.000696	0.00174	CcSEcCtD
Levobupivacaine—Anaemia—Citalopram—alcohol dependence	0.000691	0.00173	CcSEcCtD
Levobupivacaine—Asthenia—Naltrexone—alcohol dependence	0.000691	0.00173	CcSEcCtD
Levobupivacaine—CYP1A2—Tryptophan metabolism—ALDH2—alcohol dependence	0.000688	0.00809	CbGpPWpGaD
Levobupivacaine—Agitation—Citalopram—alcohol dependence	0.000687	0.00172	CcSEcCtD
Levobupivacaine—Angioedema—Citalopram—alcohol dependence	0.000683	0.00171	CcSEcCtD
Levobupivacaine—Pruritus—Naltrexone—alcohol dependence	0.000681	0.00171	CcSEcCtD
Levobupivacaine—Dizziness—Acamprosate—alcohol dependence	0.000673	0.00168	CcSEcCtD
Levobupivacaine—Syncope—Citalopram—alcohol dependence	0.00067	0.00168	CcSEcCtD
Levobupivacaine—CYP3A4—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.000663	0.00779	CbGpPWpGaD
Levobupivacaine—Palpitations—Citalopram—alcohol dependence	0.00066	0.00165	CcSEcCtD
Levobupivacaine—Diarrhoea—Naltrexone—alcohol dependence	0.000659	0.00165	CcSEcCtD
Levobupivacaine—Loss of consciousness—Citalopram—alcohol dependence	0.000657	0.00165	CcSEcCtD
Levobupivacaine—CYP1A2—Melatonin metabolism and effects—MAOA—alcohol dependence	0.000655	0.00769	CbGpPWpGaD
Levobupivacaine—Cough—Citalopram—alcohol dependence	0.000652	0.00163	CcSEcCtD
Levobupivacaine—Convulsion—Citalopram—alcohol dependence	0.000647	0.00162	CcSEcCtD
Levobupivacaine—CYP1A2—Biological oxidations—ADH6—alcohol dependence	0.000647	0.00761	CbGpPWpGaD
Levobupivacaine—Vomiting—Acamprosate—alcohol dependence	0.000647	0.00162	CcSEcCtD
Levobupivacaine—Hypertension—Citalopram—alcohol dependence	0.000645	0.00162	CcSEcCtD
Levobupivacaine—CYP1A2—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.00064	0.00752	CbGpPWpGaD
Levobupivacaine—SCN4A—Axon guidance—GRIN2B—alcohol dependence	0.000638	0.0075	CbGpPWpGaD
Levobupivacaine—Headache—Acamprosate—alcohol dependence	0.000637	0.0016	CcSEcCtD
Levobupivacaine—Dizziness—Naltrexone—alcohol dependence	0.000636	0.00159	CcSEcCtD
Levobupivacaine—Arthralgia—Citalopram—alcohol dependence	0.000636	0.00159	CcSEcCtD
Levobupivacaine—CYP1A2—Phase II conjugation—GGT2—alcohol dependence	0.000636	0.00747	CbGpPWpGaD
Levobupivacaine—Anxiety—Citalopram—alcohol dependence	0.000634	0.00159	CcSEcCtD
Levobupivacaine—Unspecified disorder of skin and subcutaneous tissue—Citalopram—alcohol dependence	0.000632	0.00158	CcSEcCtD
Levobupivacaine—SCN10A—brain—alcohol dependence	0.000631	0.0379	CbGeAlD
Levobupivacaine—CYP3A4—Tryptophan metabolism—MAOB—alcohol dependence	0.000625	0.00734	CbGpPWpGaD
Levobupivacaine—SCN10A—Axon guidance—GRIN2B—alcohol dependence	0.000615	0.00723	CbGpPWpGaD
Levobupivacaine—Confusional state—Citalopram—alcohol dependence	0.000615	0.00154	CcSEcCtD
Levobupivacaine—Vomiting—Naltrexone—alcohol dependence	0.000612	0.00153	CcSEcCtD
Levobupivacaine—Oedema—Citalopram—alcohol dependence	0.00061	0.00153	CcSEcCtD
Levobupivacaine—Anaphylactic shock—Citalopram—alcohol dependence	0.00061	0.00153	CcSEcCtD
Levobupivacaine—Infection—Citalopram—alcohol dependence	0.000606	0.00152	CcSEcCtD
Levobupivacaine—Nausea—Acamprosate—alcohol dependence	0.000604	0.00151	CcSEcCtD
Levobupivacaine—Headache—Naltrexone—alcohol dependence	0.000603	0.00151	CcSEcCtD
Levobupivacaine—Shock—Citalopram—alcohol dependence	0.0006	0.0015	CcSEcCtD
Levobupivacaine—Nervous system disorder—Citalopram—alcohol dependence	0.000598	0.0015	CcSEcCtD
Levobupivacaine—Tachycardia—Citalopram—alcohol dependence	0.000595	0.00149	CcSEcCtD
Levobupivacaine—Skin disorder—Citalopram—alcohol dependence	0.000592	0.00148	CcSEcCtD
Levobupivacaine—Hyperhidrosis—Citalopram—alcohol dependence	0.00059	0.00148	CcSEcCtD
Levobupivacaine—Nausea—Naltrexone—alcohol dependence	0.000572	0.00143	CcSEcCtD
Levobupivacaine—Hypotension—Citalopram—alcohol dependence	0.00057	0.00143	CcSEcCtD
Levobupivacaine—CYP3A4—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.000564	0.00662	CbGpPWpGaD
Levobupivacaine—Musculoskeletal discomfort—Citalopram—alcohol dependence	0.000556	0.00139	CcSEcCtD
Levobupivacaine—Insomnia—Citalopram—alcohol dependence	0.000552	0.00138	CcSEcCtD
Levobupivacaine—CYP1A2—Tryptophan metabolism—CYP2E1—alcohol dependence	0.00055	0.00646	CbGpPWpGaD
Levobupivacaine—Paraesthesia—Citalopram—alcohol dependence	0.000548	0.00137	CcSEcCtD
Levobupivacaine—Dyspnoea—Citalopram—alcohol dependence	0.000544	0.00136	CcSEcCtD
Levobupivacaine—Somnolence—Citalopram—alcohol dependence	0.000542	0.00136	CcSEcCtD
Levobupivacaine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—alcohol dependence	0.000541	0.00635	CbGpPWpGaD
Levobupivacaine—Dyspepsia—Citalopram—alcohol dependence	0.000537	0.00134	CcSEcCtD
Levobupivacaine—CYP1A2—Biological oxidations—ADH1A—alcohol dependence	0.000536	0.0063	CbGpPWpGaD
Levobupivacaine—CYP3A4—Tryptophan metabolism—ALDH2—alcohol dependence	0.000531	0.00624	CbGpPWpGaD
Levobupivacaine—CYP1A2—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000531	0.00623	CbGpPWpGaD
Levobupivacaine—Decreased appetite—Citalopram—alcohol dependence	0.00053	0.00133	CcSEcCtD
Levobupivacaine—Gastrointestinal disorder—Citalopram—alcohol dependence	0.000527	0.00132	CcSEcCtD
Levobupivacaine—Constipation—Citalopram—alcohol dependence	0.000522	0.00131	CcSEcCtD
Levobupivacaine—Pain—Citalopram—alcohol dependence	0.000522	0.00131	CcSEcCtD
Levobupivacaine—CYP1A2—digestive system—alcohol dependence	0.000511	0.0307	CbGeAlD
Levobupivacaine—Feeling abnormal—Citalopram—alcohol dependence	0.000503	0.00126	CcSEcCtD
Levobupivacaine—CYP3A4—Biological oxidations—ADH6—alcohol dependence	0.0005	0.00587	CbGpPWpGaD
Levobupivacaine—Gastrointestinal pain—Citalopram—alcohol dependence	0.000499	0.00125	CcSEcCtD
Levobupivacaine—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.000494	0.00581	CbGpPWpGaD
Levobupivacaine—CYP1A2—blood—alcohol dependence	0.000487	0.0293	CbGeAlD
Levobupivacaine—Urticaria—Citalopram—alcohol dependence	0.000484	0.00121	CcSEcCtD
Levobupivacaine—Body temperature increased—Citalopram—alcohol dependence	0.000482	0.00121	CcSEcCtD
Levobupivacaine—Abdominal pain—Citalopram—alcohol dependence	0.000482	0.00121	CcSEcCtD
Levobupivacaine—CYP1A2—Arachidonic acid metabolism—GGT1—alcohol dependence	0.000473	0.00555	CbGpPWpGaD
Levobupivacaine—CYP1A2—Biological oxidations—ADH4—alcohol dependence	0.000456	0.00536	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—GRIN2B—alcohol dependence	0.000455	0.00535	CbGpPWpGaD
Levobupivacaine—CYP1A2—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000451	0.0053	CbGpPWpGaD
Levobupivacaine—Hypersensitivity—Citalopram—alcohol dependence	0.000449	0.00113	CcSEcCtD
Levobupivacaine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000445	0.00523	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—GRIN2B—alcohol dependence	0.000439	0.00516	CbGpPWpGaD
Levobupivacaine—CYP1A2—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000439	0.00516	CbGpPWpGaD
Levobupivacaine—Asthenia—Citalopram—alcohol dependence	0.000438	0.0011	CcSEcCtD
Levobupivacaine—Pruritus—Citalopram—alcohol dependence	0.000431	0.00108	CcSEcCtD
Levobupivacaine—CYP3A4—Tryptophan metabolism—CYP2E1—alcohol dependence	0.000425	0.00499	CbGpPWpGaD
Levobupivacaine—CYP1A2—endocrine gland—alcohol dependence	0.000422	0.0254	CbGeAlD
Levobupivacaine—Diarrhoea—Citalopram—alcohol dependence	0.000417	0.00105	CcSEcCtD
Levobupivacaine—CYP3A4—Biological oxidations—ADH1A—alcohol dependence	0.000414	0.00486	CbGpPWpGaD
Levobupivacaine—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000409	0.00481	CbGpPWpGaD
Levobupivacaine—Dizziness—Citalopram—alcohol dependence	0.000403	0.00101	CcSEcCtD
Levobupivacaine—CYP1A2—Biological oxidations—ADH7—alcohol dependence	0.000388	0.00456	CbGpPWpGaD
Levobupivacaine—Vomiting—Citalopram—alcohol dependence	0.000388	0.000971	CcSEcCtD
Levobupivacaine—Headache—Citalopram—alcohol dependence	0.000382	0.000957	CcSEcCtD
Levobupivacaine—CYP1A2—liver—alcohol dependence	0.000381	0.0229	CbGeAlD
Levobupivacaine—CYP1A2—Biological oxidations—GGT2—alcohol dependence	0.000372	0.00437	CbGpPWpGaD
Levobupivacaine—CYP3A4—digestive system—alcohol dependence	0.00037	0.0222	CbGeAlD
Levobupivacaine—Nausea—Citalopram—alcohol dependence	0.000362	0.000907	CcSEcCtD
Levobupivacaine—CYP1A2—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000361	0.00424	CbGpPWpGaD
Levobupivacaine—CYP3A4—blood—alcohol dependence	0.000352	0.0212	CbGeAlD
Levobupivacaine—CYP3A4—Biological oxidations—ADH4—alcohol dependence	0.000352	0.00414	CbGpPWpGaD
Levobupivacaine—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000348	0.00409	CbGpPWpGaD
Levobupivacaine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000343	0.00403	CbGpPWpGaD
Levobupivacaine—CYP1A2—Biological oxidations—ADH1B—alcohol dependence	0.00034	0.004	CbGpPWpGaD
Levobupivacaine—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000339	0.00398	CbGpPWpGaD
Levobupivacaine—CYP3A4—endocrine gland—alcohol dependence	0.000306	0.0184	CbGeAlD
Levobupivacaine—CYP1A2—Phase II conjugation—GGT1—alcohol dependence	0.000301	0.00353	CbGpPWpGaD
Levobupivacaine—CYP3A4—Biological oxidations—ADH7—alcohol dependence	0.000299	0.00352	CbGpPWpGaD
Levobupivacaine—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000297	0.00349	CbGpPWpGaD
Levobupivacaine—CYP3A4—Biological oxidations—GGT2—alcohol dependence	0.000287	0.00337	CbGpPWpGaD
Levobupivacaine—CYP3A4—nervous system—alcohol dependence	0.000286	0.0172	CbGeAlD
Levobupivacaine—CYP1A2—Biological oxidations—MAOB—alcohol dependence	0.000282	0.00331	CbGpPWpGaD
Levobupivacaine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000278	0.00327	CbGpPWpGaD
Levobupivacaine—CYP3A4—liver—alcohol dependence	0.000276	0.0166	CbGeAlD
Levobupivacaine—CYP3A4—central nervous system—alcohol dependence	0.000275	0.0166	CbGeAlD
Levobupivacaine—CYP3A4—Biological oxidations—ADH1B—alcohol dependence	0.000262	0.00308	CbGpPWpGaD
Levobupivacaine—CYP1A2—Biological oxidations—ALDH2—alcohol dependence	0.00024	0.00282	CbGpPWpGaD
Levobupivacaine—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000238	0.0028	CbGpPWpGaD
Levobupivacaine—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000229	0.00269	CbGpPWpGaD
Levobupivacaine—CYP3A4—Biological oxidations—MAOB—alcohol dependence	0.000217	0.00256	CbGpPWpGaD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—alcohol dependence	0.000196	0.0023	CbGpPWpGaD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—EP300—alcohol dependence	0.000196	0.0023	CbGpPWpGaD
Levobupivacaine—CYP1A2—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000193	0.00227	CbGpPWpGaD
Levobupivacaine—CYP1A2—Biological oxidations—CYP2E1—alcohol dependence	0.000192	0.00225	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000189	0.00222	CbGpPWpGaD
Levobupivacaine—CYP3A4—Biological oxidations—ALDH2—alcohol dependence	0.000185	0.00217	CbGpPWpGaD
Levobupivacaine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000184	0.00216	CbGpPWpGaD
Levobupivacaine—CYP1A2—Biological oxidations—GGT1—alcohol dependence	0.000176	0.00207	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—EP300—alcohol dependence	0.000164	0.00192	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—EP300—alcohol dependence	0.000158	0.00185	CbGpPWpGaD
Levobupivacaine—CYP1A2—Biological oxidations—MAOA—alcohol dependence	0.000158	0.00185	CbGpPWpGaD
Levobupivacaine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000149	0.00175	CbGpPWpGaD
Levobupivacaine—CYP3A4—Biological oxidations—CYP2E1—alcohol dependence	0.000148	0.00174	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000146	0.00171	CbGpPWpGaD
Levobupivacaine—CYP3A4—Biological oxidations—GGT1—alcohol dependence	0.000136	0.00159	CbGpPWpGaD
Levobupivacaine—CYP3A4—Biological oxidations—MAOA—alcohol dependence	0.000122	0.00143	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—ADH6—alcohol dependence	0.000111	0.0013	CbGpPWpGaD
Levobupivacaine—CYP1A2—Biological oxidations—POMC—alcohol dependence	0.000103	0.00121	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—ADH1A—alcohol dependence	9.17e-05	0.00108	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—ADH6—alcohol dependence	8.54e-05	0.001	CbGpPWpGaD
Levobupivacaine—CYP3A4—Biological oxidations—POMC—alcohol dependence	7.92e-05	0.00093	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—ADH4—alcohol dependence	7.8e-05	0.000916	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—ADH1A—alcohol dependence	7.08e-05	0.000832	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	6.75e-05	0.000793	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—ADH7—alcohol dependence	6.63e-05	0.000779	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—GGT2—alcohol dependence	6.36e-05	0.000747	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—ADH4—alcohol dependence	6.02e-05	0.000707	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—ADH1B—alcohol dependence	5.82e-05	0.000683	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—ADH7—alcohol dependence	5.12e-05	0.000601	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—GGT2—alcohol dependence	4.91e-05	0.000577	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—MAOB—alcohol dependence	4.82e-05	0.000566	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—ADH1B—alcohol dependence	4.49e-05	0.000527	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—ALDH2—alcohol dependence	4.1e-05	0.000481	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	3.94e-05	0.000463	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—MAOB—alcohol dependence	3.72e-05	0.000437	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—GOT2—alcohol dependence	3.48e-05	0.000409	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—CYP2E1—alcohol dependence	3.28e-05	0.000385	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—ALDH2—alcohol dependence	3.16e-05	0.000372	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—GGT1—alcohol dependence	3.01e-05	0.000353	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—GOT1—alcohol dependence	3.01e-05	0.000353	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—MAOA—alcohol dependence	2.7e-05	0.000317	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—GOT2—alcohol dependence	2.69e-05	0.000316	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	2.61e-05	0.000307	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—CYP2E1—alcohol dependence	2.53e-05	0.000297	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—GOT1—alcohol dependence	2.32e-05	0.000273	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—GGT1—alcohol dependence	2.32e-05	0.000273	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—MAOA—alcohol dependence	2.08e-05	0.000244	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—POMC—alcohol dependence	1.75e-05	0.000206	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—POMC—alcohol dependence	1.35e-05	0.000159	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—EP300—alcohol dependence	1.16e-05	0.000137	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—EP300—alcohol dependence	8.98e-06	0.000106	CbGpPWpGaD
